Continuous infusion of Esmolol in patients undergoing CABG surgery
Phase 3
- Conditions
- Coronary artery disease.Atherosclerotic heart disease of native coronary arteryI25.1
- Registration Number
- IRCT20200822048478N2
- Lead Sponsor
- Kashan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 66
Inclusion Criteria
Patients with ASA 2-4 undergoing elective CABG surgery
EF>40%
Exclusion Criteria
AV conduction block greater than grade 1
asthma
acute MI
HR<50
Mallampati score greater than 2
Kidney or liver failure
History of allergy or Idiosyncratic reaction to ß-blockers
Systolic blood pressure less than 100 mmHg
Diastolic blood pressure less than 50 mmHg
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method